March 15, 1:30 – 3:00 p.m. EST
Dozens of state, local, and tribal governments have sued opioid pain reliever (OPR) manufacturers for their alleged role in fueling the opioid overdose epidemic, and 41 state attorneys general are investigating potential unlawful sales and marketing practices by OPR manufacturers. While state litigation against OPR manufacturers can play a critical role in uncovering questionable industry practices, holding accountable entities that violate state or federal law, and galvanizing support for reform, states should mindful of the important ways in which OPR litigation differs from tobacco litigation.
By attending this webinar, you will:
You may qualify for CLE credit. ASLME is an approved provider of continuing legal education credits in several states ASLME will also apply for CLE credits in other states upon request. An email from ASLME regarding CLE credits will be sent to attendees following the webinar.